Biotecnología

Biotecnología

FDA Provides Update on Efforts to Increase Supply and Availability of Safe and Nutritious Infant Formula
23/06/2022 - FDA is providing an update on steps it has taken and will take to ensure safe and nutritious infant formula
FDA Infant Formula Update: June 22, 2022
23/06/2022 - FDA exercises enforcement discretion to Global Kosher to import various Kendamil infant formula products from United Kingdom following review of nutritional adequacy and safety information, including...
FDA Approves Merck’s Vaxneuvance in Infants and Children
23/06/2022 - Becomes the first pneumococcal conjugate vaccine approved in almost a decade to help protect pediatric populations.
Desarrollan un biomarcador que permitirá tratar de forma eficaz los cánceres más graves
23/06/2022 - Un nuevo estudio, publicado esta semana en la revista Nature, proporciona una serie...
COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure
22/06/2022 - COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
FDA Roundup: June 21, 2022
22/06/2022 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
FDA Announces Plans for Proposed Rule to Reduce Addictiveness of Cigarettes and Other Combusted Tobacco Products
22/06/2022 - The Biden-Harris Administration published plans for future potential regulatory actions that include the FDA’s plans to develop a proposed product standard that would establish a maximum nicotine...
New Agreement Paves Way for Development of First African-owned COVID-19 Vaccine
22/06/2022 - Afrigen and Univercells enter a new agreement to develop the first African-own COVID-19 vaccine.
Merck & Co.
22/06/2022
New Pediatric Obesity Program Makes Treatment More Accessible
21/06/2022 - A UC San Diego clinical trial finds new Guided Self-Help program is effective in treating pediatric obesity and improving family attendance rates.
Batavia Biosciences Expands HQ and R&D Services
21/06/2022 - Increases capacity for viral vectors and vaccine R&D in Netherlands.
Syner-G BioPharma Names Ron Kraus CEO
15/06/2022 - Kraus brings more than 25 years of experience leading life sciences companies.
Evotec, Janssen Enter Drug Discovery Alliance
15/06/2022 - Will evaluate Evotec’s TargetAlloMod platforms to discover first-in-class novel mode of action therapeutic candidates.
Rentschler Biopharma Appoints Kassim Kolia as VP, Business Development
15/06/2022 - Also provides an update on the progress made at the ATMP facility since it was established last year.
KBI Biopharma, Selexis Open Mammalian Development, Mfg. Facility in Geneva
15/06/2022 - ~94,000 sq.-ft. facility combines cell line development and mammalian cell manufacturing in a single location.
Lilly's Olumiant Becomes First FDA-approved Treatment for Alopecia Areata
15/06/2022 - Approval based on Lilly's BRAVE-AA1 and BRAVE-AA2 trials, the largest Phase 3 clinical trial program in Alopecia Areata to date.